Target intelligence / Profile preview

Major histocompatibility complex class II I-A^b molecule (I-A^b)

Target
I-A^b
Molecular classification
MHC class II molecule
01

Overview

The Major histocompatibility complex class II I-A^b molecule is a mouse-specific heterodimeric glycoprotein composed of alpha (Aβ^b) and beta (Aα^b) chains, encoded within the H-2 I region of the mouse MHC, functioning to present antigenic peptides to CD4+ T helper cells on professional antigen-presenting cells like dendritic cells, macrophages, and B cells. Its peptide-binding groove, formed by the α1 and β1 domains, accommodates longer peptides (13-25 amino acids) due to open ends, enabling recognition of extracellular pathogens and initiation of adaptive immune responses. During biosynthesis, it associates with the invariant chain in the endoplasmic reticulum to prevent endogenous peptide binding, followed by transport to endosomal compartments where HLA-DM homologs facilitate exchange for exogenous peptides. I-A^b is highly polymorphic, influencing peptide specificity and T cell selection in the thymus, critical for immune repertoire diversity. In disease, allelic variants like I-A^b contribute to susceptibility in models of autoimmune disorders such as type 1 diabetes and experimental autoimmune encephalomyelitis, and play roles in transplant rejection and pathogen defense. While not directly targeted by approved drugs, its modulation is explored in immunotherapy and vaccine design, posing challenges like broad immunosuppression or loss of immune surveillance.

Other names
MHC class II H-2 I-A^bH2-I-A^bI-A b
02

Biological functions

Antigen presentationImmune responseT cell activation
03

Disease associations

Autoimmune diseaseTransplant rejectionInfection
04

Safety considerations

Immunosuppression risksAutoimmunity exacerbation

Beyond the preview

Go deeper on Major histocompatibility complex class II I-A^b molecule (I-A^b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex class II I-A^b molecule (I-A^b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call